Class Action
Newsletter
All investigations Pre-settlement · Healthcare

Dupixent Lymphoma Investigation

Sanofi, Regeneron

Pre-litigation investigation into whether Dupixent (dupilumab) is linked to lymphoma and other cancers in patients treated for eczema or asthma.

Potential class
Anyone diagnosed with lymphoma or another cancer after taking Dupixent for eczema, asthma, or related conditions.
Confidential intake · Step 1 of 3

Check eligibility for legal action

Approximate date range of exposure or purchase

From
To